GSK to produce 1 bln doses of coronavirus vaccine booster in 2021
GlaxoSmithKline Plc will expand production of vaccine efficacy boosters, or adjuvants, to produce 1 billion doses in 2021 for use in shots for COVID-19, the British drugmaker said on Thursday.
from Reuters: Health News https://reut.rs/3gxyqqa
https://bit.ly/2zwRqiM